Guidance Documents
Guidance Documents
Under 28 CFR 50.26, except where expressly authorized by law or as expressly incorporated into a contract, guidance documents issued by a Department component lack the force or effect of law and do not bind the public; noncompliance with voluntary standards will not, in itself, result in any enforcement action. In addition, 28 CFR 50.27 articulates processes and procedures for DOJ’s use of guidance documents, including the use of guidance documents in litigation.
| Component | Document | Issued | Posted | ID | Topic | Overview |
|---|---|---|---|---|---|---|
| Drug Enforcement Administration (DEA) | Drug Addiction in Health Care Professionals | Not specified | February 28, 2020 | DOJ-1316651 | General | This informational pamphlet is aimed at health care professionals. It is a guide to show how they can recognize drug addiction with co-workers and/or a drug impaired co-workers. The information alerts the reader to certain signs, behaviors or symptoms that the drug impaired co-worker may exhibit. The material discusses things such as absenteeism, frequent disappearances, not meeting deadlines and work performances alternating between low and high periods of productivity. The material also identifies responsibilities and things that can be done to help the co-worker. The guide also provides signs that an individual maybe diverting controlled substances. |
| Drug Enforcement Administration (DEA) | Pharmacist Guide to Prescription Fraud | Not specified | February 28, 2020 | DOJ-1316656 | Controlled Substance Prescriptions | This information alerts the reader to certain signs, behaviors or symptoms that the drug impaired co-worker may exhibit. The material discusses things such as absenteeism, frequent disappearances, not meeting deadlines and work performances alternating between low and high periods of productivity. The material also gives the reader what are his/her responsibilities and things they can do to help to co-worker. The guide also provides signs that an individual maybe diverting controlled substances. |
| Drug Enforcement Administration (DEA) | Recognize the Abuser | Not specified | February 28, 2020 | DOJ-1316661 | General | This pamphlet is directed to medical practitioners to assist them in recognizing a drug abuser, give them actions to take when confronted by a suspected drug abuser, and responsibilities regarding proper prescribing to prevent diversion. This includes common characteristics of the drug abuser and modus operandi often used by a drug-abusing patient. |
| Drug Enforcement Administration (DEA) | Preventing the Retail Diversion of Pseudoephedrine | Not specified | February 28, 2020 | DOJ-1316666 | General | Summary of the Combat Methamphetamine Epidemic Act of 2005 (CMEA). Preventing the Retail Diversion of Pseudoephedrine, including CMEA requirements, methamphetamine background information, and DEA’s goals in combating the methamphetamine epidemic. |
| Drug Enforcement Administration (DEA) | Clarification of Title 21 CFR 1301.90 - Employee Screening - Non-Practitioners | Not specified | February 28, 2020 | DOJ-1316676 | Controlled Substance Security | This document identified a DEA regulation that may create unintended consequences for a formerly incarcerated individual that is attempting to successfully reenter society. Specifically, 21 CFR 1301.90 has been identified as such because this regulation sets forth specific questions in order for a non-practitioner to comprehensively screen employees. It also states DEA’s position on employee screening by non-practitioners in which “….obtaining information by non-practitioners is vital to fairly assess the likelihood of an employee committing a drug security breach. In this regard, it is believed that conviction of crimes and unauthorized use of controlled substances are activities that are properly subjects for injury.” Although 21 CFR 1301.90 has been identified, DEA would like to clarify that such regulation is only applicable to screening procedures for prospective employees at a non-practitioner DEA registered location where controlled substances are stored, distributed, manufactured, or otherwise handled and not applicable to prospective employees who will be employed at non-registered locations (ie corporate headquarters or sales offices). |
| Drug Enforcement Administration (DEA) | Questions and Answers for Prescribing Practitioners (EPCS) | Not specified | February 28, 2020 | DOJ-1316691 | Controlled Substance Prescriptions |
All records for prescribing of an FDA-approved narcotic for the treatment of opioid addiction need to be kept in accordance with 21 CFR 1304.03(c), 21 CFR 1304.21(b). |
| Drug Enforcement Administration (DEA) | Preventing Diversion | Not specified | February 28, 2020 | DOJ-1316711 | General | The document discusses ways for practitioners to be aware of signs that patients are trying to access drugs for diversion, such as giving vague symptoms, exaggerating pain, or avoiding tests and accessing medical history. The document also discusses ways for practitioners to avoid giving out prescriptions that could lead to diversion. Practitioners must assure they conduct medical examinations and tests while also looking out for signs of abuse when dealing with patients. |
| Office of Justice Programs (OJP) | Violent Offender Incarceration and Truth-in-Sentencing (VOI/TIS) Incentive Formula Grant Program Guidance | Not specified | February 28, 2020 | DOJ-1316776 | Grants | Guidance for states on the use and disposition requirements for VOI/TIS-funded facilities. |
| Office of Justice Programs (OJP) | Award Conditions: Civil Rights compliance | Not specified | February 28, 2020 | DOJ-1316896 | Grants | Civil rights compliance information specific to State Administering Agencies for OJP awards during or prior to FY2016 |
| Office of Justice Programs (OJP) | Federal Civil Rights Checklist | Not specified | February 28, 2020 | DOJ-1316901 | Grants | Sample civil rights compliance checklist to assist state administering agencies in review of sub-recipients |
| Office of Justice Programs (OJP) | FAQ: Filing a Civil Rights Complaint | Not specified | February 28, 2020 | DOJ-1316906 | Grants | Basic information on civil rights under the jursidiction of OCR and instructions on how to file a complaint with OCR. |
| U.S. Trustee Program | Quality Service Review of CCDE Providers | Not specified | February 28, 2020 | UST-1317801 | Credit Counseling & Debtor Education (Bankruptcy) | Template letter explaining process and documentation for quality service review of approved credit counselors and debtor financial education providers. |
| U.S. Trustee Program | Cover Letter, Chapter 11 Operating Guidelines, and Instructions for Initial Debtor Interview - Region 1 | Not specified | February 28, 2020 | UST-1317856 | Bankruptcy | Instructions for document production and participation in IDI for pro se debtors. USTP Region 1, Massachusetts. |
| U.S. Trustee Program | Cover Letter and Instructions for Initial Debtor Interview | Not specified | February 28, 2020 | UST-1317861 | Business Reorganization (Bankruptcy) | Instructions for document production and participation in Initial Debtor Interview for debtors. USTP Region 1, Massachusetts. |
| U.S. Trustee Program | LAP Implementation memo | Not specified | February 28, 2020 | UST-1317921 | Bankruptcy | Instructions as to how to implement LAP program. USTP Region 2. |
| U.S. Trustee Program | Instructions for Pro Se Single Asset Real Estate - Brooklyn | Not specified | February 28, 2020 | UST-1317926 | Bankruptcy | Instructions for document production and participation in IDI for pro se corporate debtors. USTP Region 2, Brooklyn. |
| U.S. Trustee Program | Instructions for Pro Se Small Business - Brooklyn | Not specified | February 28, 2020 | UST-1317931 | Bankruptcy | Instructions for document production and participation in IDI for pro se single asset real estate debtors. USTP Region 2, Brooklyn. |
| U.S. Trustee Program | IDI Follow-up Instructions | Not specified | February 28, 2020 | UST-1317936 | Business Reorganization (Bankruptcy) | Instructions provided to debtors following IDI requesting additional information and confirming information explained in IDI. USTP Region 2. |
| U.S. Trustee Program | Chapter 11 Trustee Guidance | Not specified | February 28, 2020 | UST-1317941 | Business Reorganization (Bankruptcy) | Instructions for Chapter 11 Trustees to explain obligations and duties to appointed trustees. USTP Region 2. |
| U.S. Trustee Program | Post Confirmation Reporting Instructions | Not specified | February 28, 2020 | UST-1317946 | Business Reorganization (Bankruptcy) | Instructions for completing post confirmation reports. USTP Region 2. |
| U.S. Trustee Program | Trustee Election Questionnaire | Not specified | February 28, 2020 | UST-1317951 | Bankruptcy | Trustee elections questionnaire for creditors with instructions. USTP Region 2. |
| U.S. Trustee Program | Guidance re failure to obtain credit counseling | Not specified | February 28, 2020 | UST-1317956 | Bankruptcy | Instructions to debtor regarding compliance with obligation to comply with obligation to obtain credit counseling. USTP Region 2. |
| U.S. Trustee Program | Guidance re failure to file pay advices | Not specified | February 28, 2020 | UST-1317961 | Bankruptcy | Instructions to debtor regarding obligation to file pay advices. USTP Region 2. |
| U.S. Trustee Program | Guidance re expiring insurance for DIP | Not specified | February 28, 2020 | UST-1317966 | Business Reorganization (Bankruptcy) | Instructions to debtor regarding obligation to notify UST of expiring insurance. USTP Region 2. |
| U.S. Trustee Program | Guidance converted case 13 - 7 | Not specified | February 28, 2020 | UST-1317971 | Bankruptcy | Inquiry and Instructions to debtors following conversion from chapter 13 to chapter 7. USTP Region 2. |